Related Experiment Video
Updated: Jul 11, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Immune response in leukodystrophies
Florian Eichler1, Keith Van Haren
1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. feichler@partners.org
The immune system significantly impacts leukodystrophy progression and treatment. This review compares immune responses in X-linked adrenoleukodystrophy, metachromatic leukodystrophy, and vanishing white-matter disease.
Area of Science:
- Neuroimmunology
- Genetics
- Biochemistry
Background:
- Leukodystrophies are genetic white matter disorders with explored genetics and biochemistry.
- The role of the immune system in leukodystrophy pathogenesis and treatment response is understudied.
Purpose of the Study:
- To compare the distinct immune responses in three common leukodystrophies.
- To highlight biochemical, pathological, and clinical differences focusing on immune involvement.
- To review current immunomodulatory therapies and stem cell transplantation for leukodystrophies.
Main Methods:
- Comparative review of existing literature on leukodystrophies.
- Analysis of immune cell profiles (lymphocytic, histiocytic) in different leukodystrophy types.
- Examination of treatment outcomes with immunomodulatory agents and hematopoietic stem-cell transplantation.
Main Results:
- X-linked adrenoleukodystrophy exhibits a severe lymphocytic inflammatory response.
- Metachromatic leukodystrophy shows a histiocytic immune response.
- Vanishing white-matter disease typically presents with no significant inflammation.
Conclusions:
- Immune responses vary significantly across different leukodystrophies.
- Understanding these immune differences is crucial for targeted therapeutic strategies.
- Further research into inflammatory markers may reveal novel therapeutic targets for leukodystrophies.
More Related Videos
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
09:01Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Inflammatory Bowel Disease III: Crohn's Disease
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Lysosomal Hydrolases